CXC趋化因子配体16及其受体与动脉粥样硬化的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


The Relationship Between CXCL16/CXCR6 and Atherosclerosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    CXC趋化因子配体16(CXCL16)是一种具有黏附分子、趋化因子、清道夫受体功能的趋化因子家族中的一员,可促进活化的T淋巴细胞与内皮细胞间的黏附,平滑肌细胞的增殖及抗原递呈细胞在炎症部位的聚集,增加巨噬细胞对氧化型低密度脂蛋白的摄取,促进泡沫细胞形成,并参与到动脉粥样硬化、血管狭窄、炎症反应的发生发展中。CXCL16及其受体与动脉粥样硬化、冠心病、脑卒中等血液循环系统疾病的发生、严重程度及预后相关,并在临床疾病发生预测中有一定作用。

    Abstract:

    CXC ligand 16 (CXCL16) as a member of the chemokines family can act as the adhesion molecule,Chemokines and scavenger receptor.It promotes the adhesion of activated T lymphocytes to endothelial cell and the proliferation of smooth muscle cell.Besides,it facilitates the aggregation of antigen presenting cells(APC) to the inflammation location and increases uptake of ox-LDL by macrophage which then convert to foam cells.It also takes part in the occurrence and development of atherosclerosis,angiostenosis and inflammation.In conclusion,CXCL16 and its receptor are related to the occurrence, severity and prognosis of the circulation system disease,such as atherosclerosis,coronary disease,stroke.And it may act as a predictor of the occurrence of clinical diseases.

    参考文献
    相似文献
    引证文献
引用本文

杨树综述,郭富强审校. CXC趋化因子配体16及其受体与动脉粥样硬化的关系[J].中国动脉硬化杂志,2012,20(9):852~856.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2011-07-25
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: